CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Basecamp Research›
Library
Basecamp Research

Basecamp Research

Biology AI company designing therapeutics from large-scale evolutionary genomic data.

HQ
London, GB
Founded
2019
Loading
Overview
Compare
Fundraising
Employees
News
Library

Basecamp Research - Library

Official pages and third-party coverage in one index.

basecamp-research.com·12 items across 10 mapped pages · Crawled Sep 26, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Product

3 pages
  1. AI Models/ai-models

    EDEN is a foundation model with programmable design capabilities that span therapeutic modalities, disease areas, and biological scales.

  2. Our Data/our-data

    We established partnerships across all seven continents to create BaseData™; the largest and most diverse evolutionary genetic dataset ever built.

  3. Therapeutic Pipeline/therapeutic-pipeline

    Today, our AI model EDEN powers three platforms spanning gene insertion, gene editing and protein design

Blog

2 pages
  1. Breaking Through Biologys Data Wall Expanding the Known Tree of Life by Over 10x Using a Global Biodiscovery Pipeline/news-research/breaking-through-biologys-data-wall-expanding-the-known-tree-of-life-by-over-10x-using-a-global-biodiscovery-pipeline
  2. News Research/news-research

    Read our latest news and research.

Press

1 page
  1. Basecamp Research Raises 140M to Advance AI Designed Therapeutics/news-research/basecamp-research-raises-140m-to-advance-ai-designed-therapeutics

    London / Boston - Wednesday 23rd September – 9am ET/ 2pm BST – Basecamp Research, a frontier AI company developing AI-designed medicines, today announced a $140M Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.

About

1 page
  1. About/about

    Basecamp Research trains frontier AI models for therapeutic design. Our EDEN models are trained on BaseData, the world’s largest proprietary evolutionary genomic dataset.

Contact

1 page
  1. Contact/contact

    We collaborate with the top teams across biopharma and are building biodiversity partnerships across the globe. Reach out! We would love to hear from you.

Homepage

1 page
  1. Homepage/

    The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how.

Terms & Conditions

1 page
  1. Policies/policies

Not yet classified

1 page
  1. basecamp-research.com/

    The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how.

Coverage

1 item
  1. Anthropic and Nvidia back Basecamp Research in $140M Series Ctech.eu/2026/09/23/anthropic-and-nvidia-back-basecamp-research-in-140m-series-c/

    London-based Basecamp Research raised $140 million in a Series C led by S32, with Nvidia’s NVentures returning and Anthropic’s Anthology Fund joining as a new investor. The round also includes the NATO Innovation Fund, Catalio, Rockefeller, European Tech Collective and the UK government’s Sovereign AI Fund. Basecamp will use the funding to train new AI models and advance its therapeutic pipeline, including in vivo cell therapy based on its Eden models.

    Sep 2026 · Tech.euNews article